(Q40557175)

21 September 2017

title

Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine--vax-TyVi--in Cuban school children and teenagers (English)

1 reference

21 September 2017

1 reference

Salmonella Typhi

1 reference

inferred from title

author name string

Rolando Felipe Ochoa Azze

1

1 reference

21 September 2017

Juan Carlos Martínez Rodríguez

2

1 reference

21 September 2017

Mónica Ginebra Iniesta

3

1 reference

21 September 2017

Xenia Rosa Ferriol Marchena

4

1 reference

21 September 2017

Vivian María Rodríguez Alfonso

5

1 reference

21 September 2017

Franklin Tomás Sotolongo Padrón

6

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

21 September 2017

1 reference

21 September 2017

volume

21

1 reference

21 September 2017

issue

21-22

1 reference

21 September 2017

page(s)

2758-2760

1 reference

Typhim Vitrade mark Vaccine

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900177-4

7 January 2021

A new typhoid vaccine composed of the Vi capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900177-4

7 January 2021

Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900177-4

7 January 2021

Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900177-4

7 January 2021

Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900177-4

7 January 2021

Experience with Salmonella typhi Vi capsular polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900177-4

7 January 2021

Showing a treatment is good because it is not bad: when does "noninferiority" imply effectiveness?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900177-4

7 January 2021

Choosing an equivalence limit for noninferiority or equivalence studies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900177-4

7 January 2021

10.1016/S0264-410X(03)00177-4

Identifiers

DOI

1 reference

21 September 2017

1 reference